Sonoma Biotherapeutics reports promising early data from phase 1 rheumatoid arthritis trial

29th October 2025 Uncategorised 0

SBT-77-7101 shows favourable safety and early signs of efficacy in patients with refractory RA

More: Sonoma Biotherapeutics reports promising early data from phase 1 rheumatoid arthritis trial
Source: News